Evaluating Response to Vitamin D3 and K2 Supplementation in Healthcare Personnel
Part of paid clinical trials in Tacoma, Washington.
- Sponsor
- Madigan Army Medical Center
- Study ID
- NCT07199829
- Status
- Recruiting
Conditions
- Hypovitaminosis
- Hypovitaminosis D
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 69 Years
- Healthy Volunteers
- Accepted
Interventions
- Vitamin Arm 1 — DIETARY_SUPPLEMENTSubject receives dietary supplement for 90 days
- Vitamin Arm 2 — DIETARY_SUPPLEMENTSubject receives dietary supplement for 90 days
- Vitamin Arm 3 — DIETARY_SUPPLEMENTSubject receives dietary supplement for 90 days
- Placebo — OTHERSubject receives placebo for 90 days
Study Details
The main purpose of this research study is to learn about the effects of supplemental vitamin D3 and vitamin K2 on blood levels and the gut microbial community, called the gut microbiome. There are many influences on blood levels of vitamin D and K to include your dietary intake, lifestyle behaviors (physical activity, sleep), genetic alterations in metabolism of these vitamins, and the gut microbial abundance and diversity. You will be asked to take one capsule containing vitamin D3 (125 mcg), vitamin K2 (180 mcg), a combination of vitamins D3 and K2 (same doses as previous), or a placebo powder for 90 days. You will also be asked to complete questionnaires, undergo body composition and blood pressure measurements, provide blood samples and a stool swab, all on 2 occasions about 3 - 4 months apart. By conducting this study, we aim to identify the frequency of common genetic alterations in vitamins D and K metabolism and establish the impact on the gut microbiome for the first time. Your participation in this study will last about 4 - 6 months and include up to 3 visits.
Key Dates
- Start date
- Mar 27, 2025
- Status verified
- Sep 2025
- Primary completion
- Mar 31, 2026
- Completion
- Mar 31, 2026
Study Design
- Enrollment
- 96 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Vitamin Arm 1Vitamin D3 125 mcg taken orally once daily for 90 days
- Active Comparator: Vitamin Arm 2Vitamin K2 180 mcg taken orally once daily for 90 days
- Active Comparator: Vitamin Arm 3Vitamin D3 125 mcg combined with vitamin K2 180 mcg taken orally once daily for 90 days
- Placebo Comparator: Placebo ArmInert capsule taken orally once daily for 90 days
Primary Outcome Measure
Gut microbiome composition [ Time Frame: 90 days ]
Central Contacts
- Mary S McCarthy, PhD253-968-3695
- Hyojin C Yi, BSN253-968-2898
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Madigan Army Medical Center | Tacoma | Washington | 98431 | Zachary T Colburn, PhD (SUB_INVESTIGATOR) Laurie H Gillette, MS (SUB_INVESTIGATOR) German G Grishpun, DO (SUB_INVESTIGATOR) Samantha J Jennings, DNP (SUB_INVESTIGATOR) Vicky N Dang, DPh (SUB_INVESTIGATOR) Racheal L Wood, PhD (SUB_INVESTIGATOR) Paola M Bregni, MS (SUB_INVESTIGATOR) |